Suppr超能文献

AAA 型 ATP 酶作为治疗靶点:结构、功能和小分子抑制剂。

AAA ATPases as therapeutic targets: Structure, functions, and small-molecule inhibitors.

机构信息

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, 91125, United States.

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, 91125, United States.

出版信息

Eur J Med Chem. 2021 Jul 5;219:113446. doi: 10.1016/j.ejmech.2021.113446. Epub 2021 Apr 10.

Abstract

ATPases Associated with Diverse Cellular Activity (AAA ATPase) are essential enzymes found in all organisms. They are involved in various processes such as DNA replication, protein degradation, membrane fusion, microtubule serving, peroxisome biogenesis, signal transduction, and the regulation of gene expression. Due to the importance of AAA ATPases, several researchers identified and developed small-molecule inhibitors against these enzymes. We discuss six AAA ATPases that are potential drug targets and have well-developed inhibitors. We compare available structures that suggest significant differences of the ATP binding pockets among the AAA ATPases with or without ligand. The distances from ADP to the His20 in the His-Ser-His motif and the Arg finger (Arg353 or Arg378) in both RUVBL1/2 complex structures bound with or without ADP have significant differences, suggesting dramatically different interactions of the binding site with ADP. Taken together, the inhibitors of six well-studied AAA ATPases and their structural information suggest further development of specific AAA ATPase inhibitors due to difference in their structures. Future chemical biology coupled with proteomic approaches could be employed to develop variant specific, complex specific, and pathway specific inhibitors or activators for AAA ATPase proteins.

摘要

ATPases Associated with Diverse Cellular Activity (AAA ATPase) 是一种存在于所有生物体中的必需酶。它们参与各种过程,如 DNA 复制、蛋白质降解、膜融合、微管服务、过氧化物酶体生物发生、信号转导和基因表达调控。由于 AAA ATPases 的重要性,一些研究人员已经识别并开发了针对这些酶的小分子抑制剂。我们讨论了六个潜在的药物靶点 AAA ATPases,它们都有很好的抑制剂。我们比较了现有的结构,这些结构表明,在有或没有配体的情况下,AAA ATPases 的 ATP 结合口袋之间存在显著差异。ADP 到 His-Ser-His 基序中的 His20 和 RUVBL1/2 复合物结构中 Arg 手指(Arg353 或 Arg378)之间的距离在有或没有 ADP 的情况下有显著差异,这表明结合位点与 ADP 的相互作用有很大的不同。总之,六个研究充分的 AAA ATPases 的抑制剂及其结构信息表明,由于它们结构的不同,可以进一步开发特定的 AAA ATPase 抑制剂。未来的化学生物学与蛋白质组学方法的结合,可以用于开发针对 AAA ATPase 蛋白的变体特异性、复合物特异性和途径特异性抑制剂或激活剂。

相似文献

4
TRIP13 - a potential drug target in cancer pharmacotherapy.TRIP13 - 癌症药物治疗中的一个潜在药物靶点。
Bioorg Chem. 2024 Oct;151:107650. doi: 10.1016/j.bioorg.2024.107650. Epub 2024 Jul 18.
6
Targeting allostery in the Dynein motor domain with small molecule inhibitors.靶向动力蛋白马达域的变构小分子抑制剂。
Cell Chem Biol. 2021 Oct 21;28(10):1460-1473.e15. doi: 10.1016/j.chembiol.2021.04.024. Epub 2021 May 19.
9
Discovery of small-molecule inhibitors of RUVBL1/2 ATPase.RUVBL1/2 ATP酶小分子抑制剂的发现。
Bioorg Med Chem. 2022 May 15;62:116726. doi: 10.1016/j.bmc.2022.116726. Epub 2022 Mar 26.

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验